Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Frontiers in Pharmacology|February 14, 2022
The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort StudyMing-Hsien Tsai, Mingchih Chen, Yen-Chun Huang, et al.Scientific Reports|November 15, 2018
Association of Serum Aluminum Levels with Mortality in Patients on Chronic HemodialysisMing-Hsien Tsai, Yu-Wei Fang, Hung-Hsiang Liou, et al.Scientific Reports|October 14, 2025
Association between glucagon-like peptide-1 receptor agonist therapy and respiratory illness in patients with type 2 diabetes: a retrospective observational cohort studyLi-Ti Ho, Yu-Wei Fang, Pei-Sung Hsu, et al.Frontiers in Medicine|October 20, 2023
An integrated machine learning predictive scheme for longitudinal laboratory data to evaluate the factors determining renal function changes in patients with different chronic kidney disease stagesMing-Hsien Tsai, Mao-Jhen Jhou, Tzu-Chi Liu, et al.Frontiers in Nutrition|February 28, 2025
Effect of dietary glycemic index on insulin resistance in adults without diabetes mellitus: a systematic review and meta-analysisYu-Ting Yu, Yu-Hsiang Fu, Yi-Hsien Chen, et al.Journal of Diabetes Investigation|March 7, 2026
Association of glucagon-like peptide-1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetesYu-Ting Yu, Ying Chun Lee, Yu-Wei Fang, et al.Scientific Reports|December 6, 2016
Association between peripheral arterial occlusive disease and cardiothoracic ratio in patients on chronic hemodialysisKang-Yi Liou, Hung-Hsiang Liou, Yu-Wei Fang, et al.European Heart Journal. Cardiovascular Pharmacotherapy|June 12, 2025
Nonsteroidal Mineralocorticoid Receptor Antagonists and Cardiovascular Events in Type 2 Diabetes: A Retrospective StudyYi-Hsien Chen, Yu-Wei Fang, Mon-Ting Chen, et al.BMC Nephrology|April 25, 2025
The protective effects of insulin on the developing of dementia in chronic kidney disease patients with hypertension and diabetes: a population-based nationwide studyYun-Yi Chen, Yi-Hsien Chen, Yu-Wei Fang, et al.Journal of the American Geriatrics Society|October 24, 2025
GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 DiabetesJui-Cheng Chen, Yu-Wei Fang, Ya-Fang Liu, et al.Pageof 8